Anxiety/Depression- AHN Flashcards
Why is depression so important to study?
Major depressive disorder (MDD) is one of the most common psychiatric disorders, affecting up to 20% of the world population across their lifetime. The World Health Organization has predicted that MDD will be the second leading cause of disability worldwide by the year 2020
1) Depression is the fourth leading cause of disability and disease worldwide.
2) Each year, 6% of adults experience an episode of depression, and over the course of their lifetime more than 15% of the population will experience an episode
3) About two-thirds of adults will at some time experience depressed mood of sufficient severity to interfere with their normal activities
4) Prevalence rates have consistently been found to be 1.5–2.5 times higher in women than in men in the age group 18–64 years.
5) 1/4 of adults with depression don’t really respond to antidepressants- little to no benefits
How is depression diagnosed?
The DSM-IV outlines the following criterion to make a diagnosis of depression. The individual must be experiencing five or more symptoms during the same 2-week period and at least one of the symptoms should be either (1) depressed mood or (2) loss of interest in “pleasure”- sex, food, socialising
Low self esteem, thoughts of worthlessness
Recurrent thoughts of death and suicide
Decreased ability to concentrate and think Weight change
Aggression in males
Sleep disturbance
Agitation or fatigue (locomotion)
Cognitive impairment (deficits in working memory, verbal fluency, processing speed, attention, and executive function)
Epidemiology of anxiety
Anxiety disorders, including panic disorder with or without agoraphobia, generalized anxiety disorder, social anxiety disorder, and PTSD are the most prevalent mental disorders. As a result they are associated with immense health care costs and a high burden of disease. According to large population-based surveys, up to 33.7% of the population are affected by an anxiety disorder during their lifetime.
Anxiety disorders are also highly comorbid with other mental disorders, such as depression
Define anxiety
Anxiety disorders are marked by excessive fear (and avoidance), often in response to specific objects or situations and in the absence of true danger, and they are extremely common in the general population.
Anxiety disorders have been viewed as maladaptive fear responses in that the frightening object becomes generalized to many other similar but non-threatening stimuli.
What did Kupfer et al.,2012 say?
It was a review stating that the neural systems that are involved in emotion and reward processing (amygdala and nucleus accumbens), regulating emotion (hippocampus, medial prefrontal cortex and anterior cingulate cortex) and cognitive control of emotion (ventrolateral prefrontal cortex and dorsolateral prefrontal cortex) are dysfunctional in depression.
Neuroimaging studies suggestuggest abnormally increased amygdala, ventral striatal, and medial prefrontal cortex activity, mostly to negative emotional stimuli, such as fearful faces. Additionally, abnormally reduced ventral striatal activity to positive emotional stimuli (Epstein et al., 2006) and in anticipation of reward (Pizzagali et al.,2009) with depression have also been reported. These findings support a bias of attention towards negative emotional stimuli, and away from positive emotional and reward-related stimuli in individuals with major depression.
What causes depression and anxiety disorders?
The pathogenesis of depression and anxiety remains largely unknown, however genetic factors have been shown to play an important role in conferring vulnerability and to the heritability of these mental disorders. The heritability of depression, for instance, estimated by family, twin and adoption studies, is 35–40% (Sullivan et al.,2000). It is important to note that depression is a multifactorial disease. A genetic predisposition or environmental risk factor per se is not sufficient to cause depression. It is generally accepted that in most people, depression is caused by interactions between a genetic predisposition and some environmental factors.
Furthemore, many groups have demonstrated the function of epigenetic mechanisms in mediating the risk and development of anxiety and depression. For instance it has been shown that adverse early experiences (e.g., low maternal care, abuse) can affect glucocorticoid receptor (GR) gene (NR3C1) expression, which stably predisposes one to anxiety and depression (Smart et al., 2015; Conti and Alvares da Silva-Conforti, 2016).
The HPA axis is known to be a major control module of the stress response in mammals, besides the autonomic nervous system. Interestingly, the hyperactivity/dysfunction of the hypothalamic-pituitary-axis (HPA) axis, which is one of the most consistent biological findings in patients with depression (Pariante and Lightman, 2008), is mediated by the GR. Furthermore FKBP51 has been shown to decrease ligand binding sensitivity of the GR, thereby directly affecting stress system (re)activity. As a result, it is no surprise that single nucleotide polymorphisms of FKBP51 have been linked to psychiatric disorders (Binder et al.,2004)
The combined evidence of early life stress and trauma and dysfunction of a major control module of the stress response propose a strong link between persistent stress and depression and anxiety. However it is difficult to verify absolutely.
Define stress… what is generally belived about its link to depression
Stress is a term often used to describe situations that are emotionally and physiologically challenging. In biological terms, stress is characterized as a state of disturbed body homeostasis. Hans Selye, a pioneer of stress research, defined stress as the ‘non-specificresponse of the body to any demand for change’.
Usually, the mediation of a stress response is beneficial, as long as the adaptive systems are activated for a short period of time and efficiently shot off again, without being chronically overstimulated. It is generally agreed that averse experiences and excessive challenges such as chronic stress clearly impose a major risk factor for the development of depression and other stress-mediated disorders (Holsboer, 2000
Outline the stress pathway
Upon stress, the HPA axis is activated and thereby cortiocotropin-releasing hormone (CRH) and vasopressin (AVP) are secreted from neurons of the paraventricluar nucleus. (Sapolsky et al., 2000). At the pituitary, CRH and AVP bind to their respective receptors and synergistically trigger the synthesis and release of pro-opiomelanocortin (POMC), the precursor for andreno- corticotropic hormone (ACTH).
Circulating ACTH reaches the secretory cells of the zona fasciculate and the zona reticluaris of the adrenal cortex via the blood stream and stimulates them to synthesize and secrete glucocorticoids (GCs) into the systemic circulation.
Glucocorticoids (cortisol in humans and corticosterone in rodents), the main hormonal end products of the HPA axis, then act on numerous organ systems, including the brain, to modulate physiology and behavior. This includes peripheral function such as metabolism and immunity, but also effects on the brain such as the regulation of neurogenesis.
The nature of a stressor can differ largely and therefore so can the stress response, as it is mediated via the HPA axis, which arises from interactions of several distinct stress-sensitive brain circuits and neuronal populations of the PVN.
What test can be predictive of depression?
Among asymptomatic first-degree relatives of depressed patients, higher stress-hormone release was detected following dexamethasone supression-test administration (Holsboer et al. 1995). In addition, individuals with childhood trauma have an increased plasma cortisol response to the dexamethasone suppression test under both conditions, with or without current major depression (Heim et al. 2008a).
The increased cortisol release may be due to impaired GR signalling.
So dexamethasone suppression test (DST) reveal increased activity/ impaired activity of HPA not only in people with MDD but with men exposed to childhood trauma. Provides an explanation as to why a risk factor for depression is childhood trauma. Heim suggests a sensitisation of the neuroendocrine stress response after childhood trauma so you are more vulnerable to getting depression after later exposure to stress.
What evidence other than impaired HPA axis show that a modified GR gene causes depression?
Weaver, 2004
Through undefined epigenetic processes, maternal effects influence the development of defensive responses to threat in organisms ranging from plants to mammals. In the rat, such effects are mediated by variations in maternal behavior, which serve as the basis for the transmission of individual differences in stress responses from mother to offspring.
Offspring of mothers that showed high levels of licking and arched-back nursing were found to have higher levels of demethylation of the GR DNA and higher serotonin levels, as compared to offspring of ‘low-LG-ABN’ mothers. As demethylation of GR DNA and serotonin levels drive transcription factor levels and cause increased GR expression, these offspring have a more modest HPA response to stress.
Eliminating the difference in hippocampal GR levels abolishes the effects of early experience on HPA responses to stress in adulthood, suggesting that the difference in hippocampal GR expression serves as a mechanism for the effect of early experience on the development of individual differences in HPA responses to stress5.
What role does serotonin have in the stress response?
Serotonin seems to play a key role in regulating GR transcription:
The observed effects of high versus low licking and grooming on the pups are thought to be mediated by serotonin (5-HT) projections to hippocampal neurons that stimulate 5-HT7 receptors, which are in turn coupled to cyclic AMP.
In primary hippocampal neurons in culture, activation of the cyclic AMP pathway increases the expression of the transcription factor NGFI-A ( aka zif- 268), which binds and activates the Nr3c1 (Glucocorticoid Receptor gene) promoter 5.
Furthermore, t has been suggested that serotonin can also affect local neuronal circuits projecting to the PVN, given the fact that serotonergic neurons project to regions adjacent to the PVN (Leonard, 2005).
What do patients with Cushings syndrome further give evidnece for?
Further evidence that continuous elevation of cortisol underlies depression is the fact that the majority of Cushing’s syndrome patients who suffer from hypercortisolemia also suffer from depression.
Holsboer and Ising, 2010
Major depression frequently shows signs of a disinhibited HPA axis due to an increased parvocellular CRH expression which drives production and secretion of pituitary ACTH and subsequently cortisol. CRH overexpression reflects an impaired negative GR feedback regulation as evidenced by a reduced inhibition of cortisol secretion after application of the synthetic glucocorticoid dexamethasone
Why does early life trauma have lasting effects?
The brain is highly plastic during early life and encodes acquired information into lasting memories that normally subserve adaptation.
What is the monoamine theory of depression? What are some of the criticisms of it?
This hypothesis states that MDD results from the deficiency of monamines such as serotonin and dopamine in the brain. As most of the currently available antidepressants work on monoamine transporters or receptors inhibiting reuptake (imipramine) or metabolism (iproniazid) of monoamine neurotransmitters (5-HT and NE) this does give evidence to support this hypothesis.
A criticism of this hypothesis is that it accounts for the complicated and heterogeneous clinical manifestations of MDD to deficiency of a molecule and that is far too simplistic and seen to misguide our understanding of the complexity of this disorder.
Furthermore, numerous findings, inconsistent with this hypothesis, have arisen from daily clinical observations, clinical researches and preclinical studies since the proposal of this hypothesis.
For instance there is a delayed onset of efficacy (3-4 weeks) of antidepressants, which may imply a second stage. Similarly there is an inadequate response/remission rate of typical antidepressants- 1 in 3 respond to first line treatment.